The vaccine candidate Ad5-nCoV that’s currently being held up from entering Canada by Chinese customs was developed using technology licensed from Canada’s National Research Council. The warning signs were all there.
Topic: COVID-19 vaccine candidates
The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.